about
Aging of mesenchymal stem cell in vitro.Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cellsEvaluation of antitumor activity of a TGF-beta receptor I inhibitor (SD-208) on human colon adenocarcinoma.The Beneficial Effects of Valproic Acid in Thyroid Cancer Are Mediated through Promoting Redifferentiation and Reducing Stemness Level: An In Vitro StudyDelivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations.Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cellsAnti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells.Novel pan PI3K inhibitor-induced apoptosis in APL cells correlates with suppression of telomerase: An emerging mechanism of action of BKM120.Targeting human telomerase RNA component using antisense oligonucleotide induces rapid cell death and increases ATO-induced apoptosis in APL cells.Reactive oxygen species generation and increase in mitochondrial copy number: new insight into the potential mechanism of cytotoxicity induced by aurora kinase inhibitor, AZD1152-HQPA.Reciprocal Interactions of Leukemic Cells with Bone Marrow Stromal Cells Promote Enrichment of Leukemic Stem Cell Compartments in Response to Curcumin and DaunorubicinAnti-tumor activity of PI3K-δ inhibitor in hematologic malignant cells: Shedding new light on resistance to Idelalisib.Demethylation and alterations in the expression level of the cell cycle-related genes as possible mechanisms in arsenic trioxide-induced cell cycle arrest in human breast cancer cells.Inhibition of telomerase using BIBR1532 enhances doxorubicin-induced apoptosis in pre-B acute lymphoblastic leukemia cells.Inhibition of tachykinin NK1 receptor using aprepitant induces apoptotic cell death and G1 arrest through Akt/p53 axis in pre-B acute lymphoblastic leukemia cells.Melatonin promotes ATO-induced apoptosis in MCF-7 cells: Proposing novel therapeutic potential for breast cancer.Survivin isoform expression in arsenic trioxide-treated acute promyelocytic leukemia cell line and patients: The odd expression pattern of survivin-2α.Arsenic trioxide induces cell cycle arrest and alters DNA methylation patterns of cell cycle regulatory genes in colorectal cancer cells.Significance of AZD1152 as a potential treatment against Aurora B overexpression in acute promyelocytic leukemia.Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells.The inhibitory effect of disulfiram encapsulated PLGA NPs on tumor growth: Different administration routes.Effects of silibinin on growth and invasive properties of human ovarian carcinoma cells through suppression of heregulin/HER3 pathway.Inhibitor of Aurora Kinase B Induces Differentially Cell Death and Polyploidy via DNA Damage Response Pathways in Neurological Malignancy: Shedding New Light on the Challenge of Resistance to AZD1152-HQPA.Apigenin modulates the expression levels of pro-inflammatory mediators to reduce the human insulin amyloid-induced oxidant damages in SK-N-MC cells.AZD1152-HQPA induces growth arrest and apoptosis in androgen-dependent prostate cancer cell line (LNCaP) via producing aneugenic micronuclei and polyploidy.Metabolism of arsenic trioxide in acute promyelocytic leukemia cells.Differential sensitivity of p44/p42-MAPK- and PI3K/Akt-targeted neuroblastoma subtypes to arsenic trioxide.Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis.Multitargeting and antimetastatic potentials of silibinin in human HepG-2 and PLC/PRF/5 hepatoma cells.BIBR 1532 increases arsenic trioxide-mediated apoptosis in acute promyelocytic leukemia cells: therapeutic potential for APL.Direct short-term cytotoxic effects of BIBR 1532 on acute promyelocytic leukemia cells through induction of p21 coupled with downregulation of c-Myc and hTERT transcription.Inhibitor of pan class-I PI3K induces differentially apoptotic pathways in acute leukemia cells: Shedding new light on NVP-BKM120 mechanism of action.Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action.Synergistic effects of arsenic trioxide and silibinin on apoptosis and invasion in human glioblastoma U87MG cell line.Characterization of arsenic-induced cytogenetic alterations in acute promyelocytic leukemia cell line, NB4.Tropisetron suppresses colitis-associated cancer in a mouse model in the remission stage.Autocrine human growth hormone expression leads to resistance of MCF-7 cells to tamoxifen.Identification of novel p53 target genes by cDNA AFLP in glioblastoma cells.ASXL1 and JAK2V617F gene mutation screening in Iranian patients with chronic myeloid leukemia.Expression analysis of microRNA-125 in patients with polycythemia vera and essential thrombocythemia and correlation with JAK2 allele burden and laboratory findings.
P50
Q33236089-DE0F0473-F6ED-40A3-98F3-EE63B4D152C8Q33829859-99C3D59F-8DF6-4A4B-842C-C8801B244F1CQ33830588-63C90CBA-D8B0-4A36-8943-7950BDCD9E0AQ35194528-11E0D70D-7CE5-49B3-8126-36B867FEDB5FQ36820304-6C720F12-1296-432C-9C5C-DCD2CD2D686CQ37695245-3F7276A9-5CEC-4ECD-B538-1A16A3081C35Q37739569-842631B8-A832-483F-95C5-8B144ECB0E46Q38611552-C757B575-0D35-48E5-BDA3-B0171F6B1AF3Q38680510-43B42AA8-B854-4A90-9D2A-77CF8D3B54FBQ38699374-F61917BB-4656-4DA0-A740-A9CD785F68A1Q38706127-867D3AB9-AEA1-4782-9FAD-AF27CC2A1365Q38714108-7475FDF1-2BEB-44B5-BF09-F225EBCD94F7Q38715686-F2F3EA95-0AC2-407E-A8DA-7B1DD8890DB0Q38722874-B3C84A1C-EA4E-4A3D-99E7-A1002CAB9072Q38736117-B60620AC-331D-4AF0-A432-B66E0C078096Q38738792-835B1265-0289-47F1-921E-61B9A37B5695Q38738898-197FAF4A-A490-42CA-9C68-9AA34AC97704Q38738920-7CC2A845-EE06-4226-8F52-F716024204F1Q38777275-A88CA281-8CFE-4282-9056-2494EA53196FQ38779392-77C3D3F5-1CF9-433C-A2B7-C88F5822BD25Q38781140-D3C7222F-38A9-4A96-9AD0-03783DBBDC6FQ38826628-9D7727DE-9A42-445D-852A-98ACCC93D137Q38902059-8A76F594-85E3-4607-B44B-825B12BE5FE9Q38948962-A31CC90D-A754-4CD0-ACBD-84F0DE0EE96AQ38951017-B3A7319F-E1C6-4807-BE69-C346A987C11DQ38995906-AD123178-D30B-43AD-AB01-A79D82BF70BAQ39070399-7AD51BD5-6341-4D11-A251-3193A3AC7A75Q39126339-18452887-BA0E-4E80-8850-4C2CDAC45340Q39154317-5F5F34D2-2ACA-42EA-93E5-B67527F3BF0FQ39215395-4150CD0C-0DB3-47FA-9410-EC077378F627Q39413812-580CF26D-7B2B-4677-989E-13311F36BD28Q39418236-E7B3B854-2726-451D-A700-F744F859ED56Q39445570-E0D0C08F-C1DF-457A-9B95-E23B2CA3085FQ39463690-6C54FC5A-5888-4F4C-9BA4-C2DF6E8E85FAQ39547775-7EDFEED0-5A42-46F0-BE6E-EB23DFFE00F3Q39830777-4743BD8F-BADD-4D79-AED9-6A0FA599C519Q39846694-CE8DFDDD-47BB-4E87-A072-9C37D443B5BBQ39936222-64371390-1648-431E-B411-C8C1146D403BQ40576732-294B716B-5AA5-4C5C-BB5C-8BCC37C8F994Q40901657-0A72FB03-2D39-4447-B114-02E109DB5F9C
P50
description
researcher
@en
wetenschapper
@nl
name
S H Ghaffari
@en
S H Ghaffari
@nl
type
label
S H Ghaffari
@en
S H Ghaffari
@nl
prefLabel
S H Ghaffari
@en
S H Ghaffari
@nl
P108
P106
P31
P496
0000-0002-8633-9077